Ekhart, Corine http://orcid.org/0000-0002-2252-0467
van Hunsel, Florence http://orcid.org/0000-0001-8965-3224
van Puijenbroek, Eugène http://orcid.org/0000-0002-2236-1398
Chandler, Rebecca http://orcid.org/0000-0002-9334-9046
Meldau, Eva-Lisa http://orcid.org/0000-0003-0268-7769
Taavola, Henric http://orcid.org/0000-0002-2604-2810
Norén, G. Niklas http://orcid.org/0000-0002-4595-230X
Article History
Accepted: 8 December 2021
First Online: 12 January 2022
Declarations
:
: No funding was received for the conduct of this research or the preparation of this article.
: CE, FH, EP, RC, EM, HT and NN declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: The VigiBase datasets generated and analysed during the current study are not publicly available because of agreements between contributors of data to the database used (VigiBase) and the custodian of this database. National centres (mainly national drug regulatory authorities) constituting the World Health Organization Programme for International Drug Monitoring contribute data to VigiBase, and the Uppsala Monitoring Centre is the custodian in its capacity as a World Health Organization collaborating centre for international drug monitoring.
: Not applicable.
: CE, FH, EP, RC, EM, HT, NN: concept and design of the study. RC, EM, HT, NN: database strategy research and extraction of data. CE, FH, EP, RC, EM, HT, NN: data generation, collection, analysis and interpretation of data. All authors contributed to the writing/reviewing of the manuscript and approved the final version for submission.